Resolutions

All English translations are courtesy translations only. Only the German versions are binding.

Resolution of 18 April 2013: Pharmaceuticals on the existing market (58.4 kB)
Justification of the resolution of 18 April 2013 (214.9 kB)

Resolution of 17 April 2014: Discontinuation of benefit assessments of pharmaceuticals on the existing market (40.6 kB)

 

Page
Active Substance Name Therapeutic Area Date of Resolution
Abiraterone acetate (73.9 kB) Zytiga® Prostatic Neoplasms 29/03/2012
Abiraterone acetate (new therapeutic indication) (97.7 kB) Zytiga® Prostatic Neoplasms 04/07/2013
Aclidinium bromide (75.9 kB) Eklira® Genuair® / Bretaris® Genuair® Pulmonary Disease, Chronic Obstructive 21/03/2013
Aclidinium bromide/formoterol (163.5 kB) Duaklir® Genuair®/Brimica® Genuair® Pulmonary Disease, Chronic Obstructive 16/07/2015
Afatinib (246.5 kB) Giotrif® Carcinoma, Non-Small-Cell Lung 08/05/2014
Aflibercept (59.5 kB) Eylea® neovascular (wet) age-related macular degeneration 06/06/2013
Aflibercept (102.3 kB) Zaltrap® Colorectal Neoplasms 15/08/2013
Aflibercept (new therapeutic indication) (82.1 kB) Eylea® Wet Macular Degeneration 20/03/2014
Aflibercept (new therapeutic indication) (222.1 kB) Eylea® Visual impairment due to diabetic macular oedema 05/03/2015
Aflibercept (new therapeutic indication) (104.4 kB) Eylea® visual impairment due to macular oedema secondary to retinal vein occlusion 03/09/2015
Albiglutide (275.6 kB) Eperzan® Diabetes Mellitus, Type 2 19/03/2015
Alipogene tiparvovec (95.8 kB) Glybera® Hyperlipoproteinemia Type I 16/04/2015
Aliskiren/amlodipine (119.2 kB) Rasilamlo® Hypertension 03/05/2012
Apixaban (153.1 kB) Eliquis® Arthroplasty Venous Thromboembolism 07/06/2012
Apixaban (new therapeutic indication) (87.2 kB) Eliquis® Arthroplasty, Venous Thromboembolism 20/06/2013
Apixaban (new therapeutic indication) (143.4 kB) Eliquis® deep vein thrombosis and pulmonary 19/02/2015
Apremilast (118.4 kB) Otezla® Arthritis, Psoriatic Psoriasis 06/08/2015
Ataluren (123.9 kB) Translarna™ Muscular Dystrophy, Duchenne 21/05/2015
Axitinib (88.6 kB) Inlyta® Carcinoma, Renal Cell 21/03/2013
Azilsartan medoxomil (37.6 kB) Edarbi® Hypertension 15/03/2012
Bedaquiline fumarate (53.2 kB) Sirturo® Tuberculosis, Multidrug-Resistant 21/08/2014
Belatacept (81.0 kB) Nulojix® Belatacept 05/07/2012
Belimumab (74.8 kB) Benlysta® Lupus Erythematosus, Systemic 02/08/2012
Boceprevir (113.0 kB) Victrelis® Hepatitis C, Chronic 01/03/2012
Bosutinib (74.9 kB) Bosulif® Leukemia, Chronic Myeloid 17/10/2013
Brentuximab vedotin (92.7 kB) Adcetris® Hodgkin Disease Lymphoma, anaplastic large cell lymphoma 16/05/2013
Bromfenac (55.2 kB) Yellox® Pain, Postoperative Ophthalmologic Surgical Procedures 19/01/2012
Cabazitaxel (57.6 kB) Jevtana® Prostatic Neoplasms 29/03/2012
Cabozantinib (148.9 kB) Cometriq® Thyroid Neoplasms 22/01/2015
Canagliflozin (128.1 kB) Invokana® Diabetes Mellitus, Type 2 04/09/2014
Page